Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,774.50
Ask: 1,775.50
Change: 0.00 (0.00%)
Spread: 1.00 (0.056%)
Open: 1,775.50
High: 1,778.50
Low: 1,769.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-European stocks slip after four-day run, U.S. tariffs hit Airbus

Thu, 13th Aug 2020 09:39

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)

* FTSE 100 leads declines on ex-dividend trading

* Investors confident of imminent U.S. stimulus - analysts

* Thyssenkrupp slides on flagging losses in steel unit

* Danish brewer Carlsberg falls on sales warning in key
markets
(Adds comments; updates prices)

By Sruthi Shankar and Sagarika Jaisinghani

Aug 13 (Reuters) - European stocks fell on Thursday as
simmering tensions between the United States and China, and
elusive U.S. fiscal stimulus, pushed investors to book profits
after four straight sessions of gains, while Airbus dipped as
Washington left aircraft tariffs unchanged.

The pan-European STOXX 600 was off 0.4%, with
Airbus sliding 1.2% after the U.S. government said it
would maintain 15% tariffs on planes and 25% tariffs on other
European goods, despite moves to resolve a long-standing dispute
over aircraft subsidies.

London's FTSE 100 was at the front of declines among
major European bourses, led by AstraZeneca, BP,
Diageo, Glaxosmithkline and Legal&General
, which traded without entitlement to a dividend payout.

Still, with the U.S. S&P 500 index within striking
distance of a record high, analysts said there were few cues for
global equities to pull back, with investors also disregarding
U.S-China angst.

"There's no stopping this market at the moment," said
Michael Baker, an analyst at ETX Capital.

"There's not a lot negative sentiment (and) the market is
fairly confident that a U.S. stimulus deal will be reached even
if it's a last minute one."

U.S. Democrats and Republicans remain deadlocked after weeks
of wrangling over a fifth coronavirus aid bill. President Donald
Trump on Wednesday accused congressional Democrats of not
wanting to negotiate because he was refusing to go along with
"ridiculous" spending requests unrelated to the pandemic.

In Europe, the STOXX 600 is still about 14% below its
all-time high as data points to a slower-than-expected rebound
from the pandemic. A survey on Thursday showed German companies
expect business to return to normal in an average of 11 months,
with the number even higher for firms in the services sector.

Struggling conglomerate Thyssenkrupp plunged 13.1%
after it said its steel unit would rack up 1 billion euros ($1.2
billion) in operating losses this year, raising pressure to fix
or sell the division. The stock is on course for its biggest
one-day decline in three months.

Danish brewer Carlsberg slid 4.7% on warning that
lockdowns will impact sales in the second half of the year in
its key markets of China and Western Europe.

TUI, the world's largest tourism company, fell 3.0%
as it sunk to a 1.1 billion euro ($1.30 billion) loss in the
third quarter due to the COVID-19 pandemic.
(Reporting by Sruthi Shankar in Bengaluru; Additional reporting
by Sagarika Jaisinghani; Editing by Arun Koyyur, Bernard Orr)

More News
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.